Bjurberg M - Search Results

1

FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre.

Bjurberg M, Gustavsson A, Ohlsson T, Brun E. Bjurberg M, et al. Acta Oncol. 2006;45(6):743-9. doi: 10.1080/02841860600644724. Acta Oncol. 2006. PMID: 16938818

2

Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.

Ridderheim M, Bjurberg M, Gustavsson A. Ridderheim M, et al. Among authors: bjurberg m. Support Care Cancer. 2003 Jun;11(6):371-7. doi: 10.1007/s00520-003-0451-y. Epub 2003 Mar 21. Support Care Cancer. 2003. PMID: 12768403 Clinical Trial.

3

FDG-PET in cervical cancer: staging, re-staging and follow-up.

Bjurberg M, Kjellén E, Ohlsson T, Ridderheim M, Brun E. Bjurberg M, et al. Acta Obstet Gynecol Scand. 2007;86(11):1385-91. doi: 10.1080/00016340701625388. Epub 2007 Sep 4. Acta Obstet Gynecol Scand. 2007. PMID: 17851810 Free article.

4

Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.

Bjurberg M, Henriksson E, Brun E, Ekblad L, Ohlsson T, Brun A, Kjellén E. Bjurberg M, et al. Cancer Biother Radiopharm. 2009 Jun;24(3):327-32. doi: 10.1089/cbr.2008.0556. Cancer Biother Radiopharm. 2009. PMID: 19538055

5

Prediction of patient outcome with 2-deoxy-2-[18F]fluoro-D-glucose-positron emission tomography early during radiotherapy for locally advanced cervical cancer.

Bjurberg M, Kjellén E, Ohlsson T, Bendahl PO, Brun E. Bjurberg M, et al. Int J Gynecol Cancer. 2009 Dec;19(9):1600-5. doi: 10.1111/IGC.0b013e3181c00359. Int J Gynecol Cancer. 2009. PMID: 19955945 Clinical Trial.

6

Clinical impact of 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-positron emission tomography (PET) on treatment choice in recurrent cancer of the cervix uteri.

Bjurberg M, Brun E. Bjurberg M, et al. Int J Gynecol Cancer. 2013 Nov;23(9):1642-6. doi: 10.1097/IGC.0b013e3182a50537. Int J Gynecol Cancer. 2013. PMID: 24177254

7

An anesthetic method compatible with (18)F-FDG-PET studies in mice.

Siikanen J, Sjövall J, Forslid A, Brun E, Bjurberg M, Wennerberg J, Ekblad L, Sandell A. Siikanen J, et al. Among authors: bjurberg m. Am J Nucl Med Mol Imaging. 2015 Feb 15;5(3):270-7. eCollection 2015. Am J Nucl Med Mol Imaging. 2015. PMID: 26069860 Free PMC article.

8

Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study.

Stålberg K, Bjurberg M, Borgfeldt C, Carlson J, Dahm-Kähler P, Flöter-Rådestad A, Hellman K, Hjerpe E, Holmberg E, Kjølhede P, Marcickiewicz J, Rosenberg P, Tholander B, Åvall-Lundqvist E, Högberg T. Stålberg K, et al. Among authors: bjurberg m. Acta Oncol. 2019 Nov;58(11):1628-1633. doi: 10.1080/0284186X.2019.1643036. Epub 2019 Aug 2. Acta Oncol. 2019. PMID: 31373248 Free article.

9

Metabolic parameters of [¹⁸F]FDG PET-CT before and after radiotherapy may predict survival and recurrence in cervical cancer.

Markus M, Sartor H, Bjurberg M, Trägårdh E. Markus M, et al. Among authors: bjurberg m. Acta Oncol. 2023 Feb;62(2):180-188. doi: 10.1080/0284186X.2023.2181100. Epub 2023 Feb 23. Acta Oncol. 2023. PMID: 36815676 Free article.

10

Early Metabolic Flare in Squamous Cell Carcinoma after Chemotherapy is a Marker of Treatment Sensitivity In Vitro.

Bjurberg M, Abedinpour P, Brun E, Baldetorp B, Borgström P, Wennerberg J, Kjellén E. Bjurberg M, et al. Nucl Med Mol Imaging. 2010 Sep;44(3):165-169. doi: 10.1007/s13139-010-0034-z. Epub 2010 Jun 9. Nucl Med Mol Imaging. 2010. PMID: 21151484 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters